Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat.
Research suggests that use and abuse of marijuana can be especially harmful if it occurs during adolescence, a period of vast developmental changes throughout the brain. We examined the effects of 2mg/kg (9)-tetrahydrocannabinol (THC) administered daily via intra-peritoneal injections during juvenile/early adolescence (postnatal day 22-40) or late adolescence (postnatal day 41-60) on locomotor activity, development of tolerance, and acquisition/retention of spatial avoidance in adulthood. THC caused locomotor depression in both male and female animals dosed during early adolescence but only in female animals dosed during late adolescence. Evidence of reverse tolerance to THC was seen in early adolescent animals only. In the active place avoidance test (APA), male and female animals administered THC during early adolescence made more errors on the reversal trial requiring flexibility in learning, but in animals dosed during late adolescence there were no significant sex or treatment differences. The results of the locomotor activity study indicate that females may be more sensitive to the effects of THC than males, while results of both locomotor activity and APA studies suggest that early adolescents appear to be more vulnerable to these effects than late adolescents/young adults.
Harte
Lauren C
LC
Department of Physiology/Pharmacology, Program in Neural and Behavioral Sciences, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.
Dow-Edwards
Diana
D
D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D013759:Dronabinol / Q000494:pharmacology*; D005260:Female; D006213:Hallucinogens / Q000494:pharmacology*; D008124:Locomotion / Q000187:drug effects*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012153:Retention, Psychology / Q000187:drug effects; D012193:Reversal Learning / Q000187:drug effects*; D012727:Sex Characteristics; D018709:Statistics, Nonparametric
D006213:Hallucinogens; D013759:Dronabinol
Neurotoxicol Teratol. 1995 Jan-Feb;17(1):25-30
7708016
J Cogn Neurosci. 2004 Sep;16(7):1227-33
15453975
Neuropsychopharmacology. 2008 Oct;33(11):2760-71
18172430
Crit Rev Neurobiol. 2003;15(2):91-119
14977366
J Neurochem. 1999 Dec;73(6):2447-59
10582605
Neurosci Biobehav Rev. 2002 Oct;26(6):631-64
12479840
Synapse. 1998 Nov;30(3):298-308
9776133
J Neurosci. 1991 Feb;11(2):563-83
1992016
Prog Neurobiol. 1999 Jul;58(4):315-48
10368032
Drug Alcohol Depend. 2003 Aug 20;71(2):169-77
12927655
Annu Rev Neurosci. 2007;30:123-52
17417939
Neuroscientist. 2004 Aug;10(4):372-92
15271264
Neuropsychopharmacology. 2003 Jul;28(7):1356-65
12784123
Br J Pharmacol. 2007 Jul;151(5):688-700
17502849
Drug Alcohol Depend. 2009 Aug 1;103(3):107-13
19443132
Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
10817843
Neuropsychopharmacology. 2006 Feb;31(2):462-70
16177808
Eur Neuropsychopharmacol. 2008 Nov;18(11):826-34
18674887
Behav Neurosci. 2001 Jun;115(3):695-703
11439458
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
2308954
J Pharmacol Exp Ther. 2007 Mar;320(3):1097-105
17172531
Pharmacol Biochem Behav. 1993 Nov;46(3):575-9
8278434
Pharmacol Biochem Behav. 2008 Jan;88(3):230-7
17888506
J Clin Pharmacol. 1981 Aug-Sep;21(S1):208S-214S
6271826
Neuroreport. 1993 Feb;4(2):135-8
8453049
Psychopharmacology (Berl). 2002 May;161(2):129-36
11981592
Trends Neurosci. 2005 Jul;28(7):364-70
15935487
J Neurosci. 2005 Mar 2;25(9):2413-9
15745968
Psychopharmacology (Berl). 2008 Jan;196(1):119-31
17899017
Neurosci Lett. 2008 Jul 4;439(1):89-93
18513870
Eur J Neurosci. 2001 Sep;14(5):884-6
11576193
Psychopharmacology (Berl). 2007 May;191(4):867-77
17211649
Biochem Pharmacol. 1991 Apr 15;41(8):1187-94
1848985
Behav Brain Res. 2004 Sep 23;154(1):77-83
15302113
J Pharmacol Exp Ther. 2002 Jun;301(3):915-24
12023519
Brain Res. 1993 Jul 9;616(1-2):293-302
8395305
Eur J Pharmacol. 2008 May 13;585(2-3):458-63
18423599
J Neurochem. 2008 Aug;106(4):1586-93
18513369
Cereb Cortex. 2006 Apr;16(4):553-60
16033925
Brain. 2003 Jun;126(Pt 6):1252-70
12764049
Life Sci. 1994;54(3):159-70
8289577
Eur J Pharmacol. 2008 Jan 6;578(1):37-42
17905227
Neuropsychopharmacology. 2008 Apr;33(5):1113-26
17581536
Dev Rev. 2008;28(1):62-77
18688292
Drug Alcohol Depend. 2000 Aug 1;60(2):113-9
10940538
Psychopharmacology (Berl). 2008 Dec;201(2):171-81
18695931
Synapse. 2005 Jan;55(1):1-16
15499609
Drug Alcohol Depend. 2003 Apr 1;69(3):303-10
12633916
Neuropsychopharmacology. 2005 Oct;30(10):1895-905
15812570
NIDA Res Monogr. 1997;167:59-80
9243557
Neurobiol Learn Mem. 2008 Sep;90(2):374-81
18524639
Jpn J Pharmacol. 2001 Dec;87(4):297-308
11829149
Pharmacol Biochem Behav. 2006 Mar;83(3):448-55
16631921